Publisher Health

This post was originally published on this site

The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation for patients with hypertension, Medtronic announced.

The FDA said Philips is recalling the monitoring service application used with mobile cardiac outpatient telemetry and offering data reprocessing for some patients.

In the RESILIENT trial, mobile health cardiac rehabilitation did not significantly improve outcomes in older adults who went home after being hospitalized for ischemic heart disease. (JAMA Network Open)

In two studies, artificial intelligence (AI) models, trained on 12-lead electrocardiogram features, were able to predict future development of heart failure in the general population and mortality in patients with acute chest pain. (European Heart Journal)

AI was also able to predict risk of stroke using measurements from the retina’s intricate vascular network in a U.K. Biobank cohort study. (Heart)

A cardiovascular polypill, containing a statin and three half-dose antihypertensives, could be considered high-value for an underserved population, according to economic modeling. (JAMA Cardiology)

Among veterans, hypertension control rates varied across the country by race and ethnicity, suggesting that areas with low rates of hypertension control would benefit from interventions to address disparities. (Journal of the American Heart Association)

For stroke patients with incomplete reperfusion after mechanical thrombectomy, adjunctive intra-arterial tenecteplase showed promise for getting them closer to complete recanalization in an observational pilot study. (Stroke)

A study showed that the changes to donor heart allocation in the last decade have not benefited infants and children with cardiomyopathy or adults with congenital heart disease. (Circulation)

In a prespecified analysis of the FINEARTS-HF trial, heart failure patients who received finerenone (Kerendia) had an initial decline in estimated glomerular filtration rate — but it was not clear that this was a predictor of poor outcomes. (Journal of the American College of Cardiology)

There was also a reduced risk of new-onset diabetes associated with use of finerenone in another FINEARTS-HF analysis. (Lancet Diabetes & Endocrinology)

Among patients with end-stage heart failure and low pulmonary capillary wedge pressure, left ventricular assist device therapy was associated with milder but significant improvements in functional capacity and quality of life compared with those with high pulmonary capillary wedge pressure. (Circulation: Heart Failure)

An international study showed that the quality of care for patients with acute heart failure is worse in lower-income countries. (eClinicalMedicine)

Preclinical work suggested that cholesterol-lowering therapy can also dampen PIN1 activity, a driver of bladder cancer. (Cancer Discovery)